Company registration number 15947894 (England and Wales)
THE PATHWAY CLINIC LTD
FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 30 SEPTEMBER 2025
PAGES FOR FILING WITH REGISTRAR
THE PATHWAY CLINIC LTD
CONTENTS
Page
Balance sheet
1
Statement of changes in equity
2
Notes to the financial statements
3 - 5
THE PATHWAY CLINIC LTD
BALANCE SHEET
AS AT
30 SEPTEMBER 2025
30 September 2025
- 1 -
2025
Notes
£
£
Current assets
Debtors
3
8,250
Cash at bank and in hand
58
8,308
Creditors: amounts falling due within one year
4
(8,306)
Net current assets
2
Capital and reserves
Called up share capital
5
1
Profit and loss reserves
1
Total equity
2

For the financial period ended 30 September 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he member has not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476.

The director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved and signed by the director and authorised for issue on 10 June 2026
H Burke-Smith
Director
Company registration number 15947894 (England and Wales)
THE PATHWAY CLINIC LTD
STATEMENT OF CHANGES IN EQUITY
FOR THE PERIOD ENDED 30 SEPTEMBER 2025
- 2 -
Share capital
Profit and loss reserves
Total
Notes
£
£
£
Period ended 30 September 2025:
Profit and total comprehensive income
-
28,335
28,335
Issue of share capital
5
1
-
1
Dividends
-
(28,334)
(28,334)
Balance at 30 September 2025
1
1
2
THE PATHWAY CLINIC LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 30 SEPTEMBER 2025
- 3 -
1
Accounting policies
Company information

The Pathway Clinic Ltd is a private company limited by shares incorporated in England and Wales. The registered office is 53 Sheen Road, Richmond, London, TW9 1YH.

1.1
Reporting period

The period covered by these financial statements is 55 weeks due to this being the first accounting period since registration.

1.2
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.3
Revenue

Revenue comprises sales of goods or services provided to customers net of value added tax and other sales taxes, less an appropriate deduction for actual and expected returns and discounts. Revenue is recognised when performance obligations are satisfied and the control of goods or services is transferred to the buyer. Where the performance obligation is satisfied over time, revenue is recognised in accordance with its progress towards complete satisfaction of that performance obligation.

1.4
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Debtors and creditors with no stated interest rate and receivable or payable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account in other administrative expenses.

THE PATHWAY CLINIC LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 30 SEPTEMBER 2025
1
Accounting policies
(Continued)
- 4 -
1.5
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.6
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

2
Employees

The average monthly number of persons (including directors) employed by the company during the period was:

2025
Number
Total
1
3
Debtors
2025
Amounts falling due within one year:
£
Other debtors
8,250
THE PATHWAY CLINIC LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 30 SEPTEMBER 2025
- 5 -
4
Creditors: amounts falling due within one year
2025
£
Corporation tax
6,856
Other creditors
1,450
8,306
5
Called up share capital
2025
2025
Ordinary share capital
Number
£
Issued and fully paid
Ordinary of £1 each
1
1

During the year 1 ordinary share of £1 was issued and fully paid.

6
Directors' transactions

Dividends totalling £28,334 were paid in the period in respect of shares held by the company's directors.

Advances
% Rate
Opening balance
Amounts advanced
Amounts repaid
Closing balance
£
£
£
£
-
-
44,114
(35,864)
8,250
-
44,114
(35,864)
8,250
2025-09-30 2024-09-10 false false false 10 June 2026 CCH Software CCH Accounts Production 2026.100 No description of principal activity H Burke-Smith 15947894 2024-09-10 2025-09-30 15947894 2025-09-30 15947894 core:CurrentFinancialInstruments core:WithinOneYear 2025-09-30 15947894 core:CurrentFinancialInstruments 2025-09-30 15947894 core:ShareCapital 2025-09-30 15947894 core:RetainedEarningsAccumulatedLosses 2025-09-30 15947894 core:ShareCapitalOrdinaryShareClass1 2025-09-30 15947894 bus:Director1 2024-09-10 2025-09-30 15947894 core:RetainedEarningsAccumulatedLosses 2024-09-10 2025-09-30 15947894 core:ShareCapital 2024-09-10 2025-09-30 15947894 bus:OrdinaryShareClass1 2024-09-10 2025-09-30 15947894 bus:OrdinaryShareClass1 2025-09-30 15947894 bus:PrivateLimitedCompanyLtd 2024-09-10 2025-09-30 15947894 bus:SmallCompaniesRegimeForAccounts 2024-09-10 2025-09-30 15947894 bus:FRS102 2024-09-10 2025-09-30 15947894 bus:AuditExemptWithAccountantsReport 2024-09-10 2025-09-30 15947894 bus:FullAccounts 2024-09-10 2025-09-30 xbrli:pure xbrli:shares iso4217:GBP